—
Like Score—qualityScore
PriceFree
Reviews75547% positive
Inbound MLT0peers liking this
Lifetime units—no estimate
StatusLiveMixed
LiveStore ↗|Community ↗
Sales estimate not available yet
Free-to-play title. Our sales estimator only covers paid games — F2P revenue (mostly DLC + microtransactions) needs a different methodology.
How sales estimation works →01 Like Score
qualityScore = Σ inbound · log₁₀(reviews+1) · positive% · rank-bonus
Insufficient data
DCBAS
Inbound
0
×
Σ log₁₀(R+1)
—
Avg pos%
—
→ —
02 Top inbound contributors
Games whose “More Like This” lists rank Spartans Vs Zombies Defense
No inbound contributors yet · data refreshes daily
03 Spartans Vs Zombies Defense’s “More like this”
Outbound MLT · 30 games
Review score
5/ 9
% positive
47.4%cohort 71%
Total reviews
755tracked
Velocity · 30d
0 / dayest
Steam-purchase rate
100.0%flat
01 Language distribution
Reviewer interface language · count, share of total, share positive
23 languages · top 12 shown
ENEnglish55.0%41538%
RURussian12.8%9761%
ESSpanish5.2%3959%
PTBrazilian Portuguese4.9%3776%
DEGerman4.0%3050%
PLPolish3.3%2564%
ZHSimplified Chinese2.5%1937%
FRFrench2.4%1850%
TWTraditional Chinese2.1%1650%
TRTurkish1.9%1464%
ITItalian1.1%850%
HUHungarian1.1%863%
02 Reviews by playtime
Hours played at time of review · positive% per bucket
0-1h 404
36%positive
1-10h 297
59%positive
10-100h 53
68%positive
100h+ 1
100%positive
03 Monthly timeline
Reviews per month · positive vs negative stacked · since launch
Positive 358Negative 397
4073052041020
15·0116·0217·0518·1020·0521·1023·1225·0526·03
04 Breakdowns
Reviews segmented · count, % of total, % positive
755 reviews
Free product
0/ 755
0.0% of total— no data
Early access
0/ 755
0.0% of total— no data
Key activation
0/ 755
0.0% of total— no data
Steam Deck
1/ 755
0.1% of total100% positive
Steam purchase
755/ 755
100.0% of total47% positive
Recommended
358/ 755
47.4% of total— votedUp
Not recommended
397/ 755
52.6% of total— votedDown
Reviews crawled
755/ 755
100.0% of total47% positive
755 reviews · 47% positive
Detailed reviewer overlap is being computed. Check back soon.